Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
10/13/2025
CSPC's Novel siRNA Therapy Gains U.S. Green Light for Clinical Trials
10/13/2025
USB's Zilbrysq Wins Chinese Approval
10/13/2025
Kelun-Biotech Wins China Approval for TROP2 ADC in EGFR-Mutant NSCLC A...
10/13/2025
PegBio Signs Exclusive Licensing Term Sheet with UAE's PDC for PB-119
10/13/2025
Micot Pharma Completes Over CNY 200M Series D Financing, Advances Towa...
10/13/2025
Chengdu NRT Raises ~CNY 800M in Series D Financing to Advance Radiopha...
10/13/2025
Expedition Therapeutics Secures USD 165M in Oversubscribed Series A
10/13/2025
Walgreens Boots Alliance Fully Exits Nanjing Pharma
10/13/2025
Hope Medicine Reports Positive Global Phase 2 Results for HMI-115
10/13/2025
4B Technologies' Novel NGF Receptor Inhibitor 4B03-04 Receives FDA IND...
10/13/2025
Zenas Secures Global Rights to InnoCare's Orelabrutinib and Next-Gen I...
10/13/2025
Eccogene Files for Hong Kong IPO
10/13/2025
CF PharmaTech Soars 161% on Hong Kong IPO Debut
10/13/2025
Kelun-Biotech Presents Promising Phase 1 Data for CLDN18.2 ADC SKB315
10/13/2025
Huadao Bio Secures Over CNY 100M in Series D+2 Financing
10/13/2025
AviadoBio and UgeneX Enter Exclusive Option-License Deal to Develop Op...
10/13/2025
China Introduces New Regulations to Govern Clinical Research and Appli...
10/13/2025
CDE Issues Guidance to Address Common Challenges in Pediatric Drug Dev...
10/13/2025
CDE Solicits Comments on Draft Guidelines for Bioequivalence Risk Asse...
10/13/2025
CDE Seeks Input on Draft Technical Requirements for Sodium Iodide [131...
10/13/2025
Two Decades of Pediatric Drug Trials in China Reveal Progress and Pers...
10/13/2025
Lundbeck's Epilepsy Drug Bexicaserin Granted Breakthrough Therapy Stat...
10/13/2025
Hansoh Pharma Reports Phase II Data for Oral B7H3 ADC HS-20093
10/13/2025
Lepu Reports Early Clinical Data for ADC Programs in Various Cancers
10/13/2025
Huadao Secures Over CNY 100M in Series D+2 Financing to Advance CAR-T ...
10/13/2025
China's Innovative Drug Sector Secures Over CNY 4.2B in Q3 Financing, ...
10/13/2025
U.S. Senate Approves Revised China Biotech Competition Bill with Softe...
10/8/2025
China Biopharma Financing Rebounds in September as IPO Pipeline Surges
10/8/2025
License-Out Deals in China Drop Sharply in September Amid Steady Deal ...
10/8/2025
Only Two Novel Drugs Win China Approval in September as Local Innovati...
Page:
1
/
794
Total number of articles:
23805
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit